Here, ipilimumab turned a “cold” PCa tumour to “hot” by bringing in T cells to the tumour but simultaneously activated unneeded PD-L1, and this was blocked with nivolumab that intercepted PD1/PD-L1interaction and therefore freed the T cells to attack tumour cells. The gene discussed is PDCD1; the disease is posterior cortical atrophy.